CCL18 and pancreatic neoplasm: To identify and quantify the amount of infiltrated TAMs with the M2 phenotype, we tested the expression of CCL18, the hallmark of TAMs in paraffin-embedded pancreatic cancer samples by immunohistochemistry (IHC).